Ligand Pharmaceuticals
LGND
LGND
234 hedge funds and large institutions have $1.45B invested in Ligand Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 42 funds opening new positions, 81 increasing their positions, 74 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
6% more funds holding
Funds holding: 221 → 234 (+13)
2.93% more ownership
Funds ownership: 93.16% → 96.09% (+2.9%)
9% more repeat investments, than reductions
Existing positions increased: 81 | Existing positions reduced: 74
Holders
234
Holding in Top 10
4
Calls
$6.3M
Puts
$665K
Top Buyers
| 1 | +$49.4M | |
| 2 | +$24M | |
| 3 | +$21.8M | |
| 4 |
FMI
F/M Investments
Washington,
District of Columbia
|
+$11.4M |
| 5 |
PCMF
Private Capital Management (Florida)
Naples,
Florida
|
+$11.3M |
Top Sellers
| 1 | -$35.9M | |
| 2 | -$5.61M | |
| 3 | -$5.02M | |
| 4 |
Morgan Stanley
New York
|
-$4.85M |
| 5 |
Pictet Asset Management
Carouge,
Switzerland
|
-$4.69M |